SS

Sachin Swami

Active Director Director DIN 09043748
DIN 09043748 First appointment Jan 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2021
Shareholding value Locked Premium profile

About Sachin Swami

Data last updated:

Sachin Swami has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Lozip Pharma Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09043748
Primary Designation Director
First Appointment 27 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Lozip Pharma Limited U24290MH2021PLC354143
Director27 Jan 20212021Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lozip Pharma Limited
Premium access

Shareholding and investment profile for Sachin Swami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Swami

Sachin Swami has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Lozip Pharma Limited. Engaged in General Business. Contributes to corporate operations.

Sachin Swami is associated with 1 company as Director.

Sachin Swami has expertise in General Business.

Sachin Swami has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available